Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Heart Lung Circ. 2016 Jan 19;25(5):425–434. doi: 10.1016/j.hlc.2016.01.002

Figure 4. miRNA-based therapies for the treatment of heart failure.

Figure 4

miRNAs implicated in calcium homeostasis, cardiac contractility, adaptive heart growth or myocyte proliferation are dysregulated in the diseased heart. Administration of miRNA inhibitors or mimics in preclinical models of cardiac stress reduced pathology and improved heart function. This demonstrates the therapeutic potential of miRNAs for the treatment of heart failure.